63 related articles for article (PubMed ID: 6584944)
1. Prostaglandin E2 production by human tumors. Defense mechanism against the host? A preliminary report.
Attallah A; Lee JB; Ambrus JL; Ambrus CM; Karakousis C; Takita H
Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):195-201. PubMed ID: 6584944
[TBL] [Abstract][Full Text] [Related]
2. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 synthesis by human primary and metastatic bone tumors in culture.
Gebhardt MC; Lippiello L; Bringhurst FR; Mankin HJ
Clin Orthop Relat Res; 1985 Jun; (196):300-5. PubMed ID: 3858043
[TBL] [Abstract][Full Text] [Related]
4. Production of prostaglandin E2 by tumor cells in vitro.
Owen K; Gomolka D; Droller MJ
Cancer Res; 1980 Sep; 40(9):3167-71. PubMed ID: 7427935
[TBL] [Abstract][Full Text] [Related]
5. [Hypercalcemia in large cell lymphoma. Possible role of prostaglandins E2 (author's transl)].
Boissonnas A; Khalifa P; Sereni D; Mathiot C; Vacher-Lavenu MC; Hornych A; Cremer GA; Laroche C
Ann Med Interne (Paris); 1982; 133(3):186-91. PubMed ID: 6954869
[TBL] [Abstract][Full Text] [Related]
6. Role of prostaglandins in the production of hypercalcemia by tumors.
Tashjian AH
Cancer Res; 1978 Nov; 38(11 Pt 2):4138-41. PubMed ID: 698957
[TBL] [Abstract][Full Text] [Related]
7. Non-small cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production.
Huang M; Sharma S; Mao JT; Dubinett SM
J Immunol; 1996 Dec; 157(12):5512-20. PubMed ID: 8955201
[TBL] [Abstract][Full Text] [Related]
8. Conjugated linoleic acid (CLA) modulates prostaglandin E2 (PGE2) signaling in canine mammary cells.
Wang LS; Huang YW; Liu S; Chang HL; Ye W; Shu S; Sugimoto Y; Funk JA; Smeaks DD; Hill LN; Lin YC
Anticancer Res; 2006; 26(2A):889-98. PubMed ID: 16619484
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells.
Rolland PH; Martin PM; Jacquemier J; Rolland AM; Toga M
J Natl Cancer Inst; 1980 May; 64(5):1061-70. PubMed ID: 6767871
[TBL] [Abstract][Full Text] [Related]
10. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.
Sharma S; Yang SC; Zhu L; Reckamp K; Gardner B; Baratelli F; Huang M; Batra RK; Dubinett SM
Cancer Res; 2005 Jun; 65(12):5211-20. PubMed ID: 15958566
[TBL] [Abstract][Full Text] [Related]
11. Cytokines differentially regulate the synthesis of prostanoid and nitric oxide mediators in tumorigenic versus non-tumorigenic mouse lung epithelial cell lines.
Dwyer-Nield LD; Srebernak MC; Barrett BS; Ahn J; Cosper P; Meyer AM; Kisley LR; Bauer AK; Thompson DC; Malkinson AM
Carcinogenesis; 2005 Jul; 26(7):1196-206. PubMed ID: 15746162
[TBL] [Abstract][Full Text] [Related]
12. Deficient immunity in head and neck cancer due to excessive monocyte production of prostaglandins.
Berlinger NT
Laryngoscope; 1984 Nov; 94(11 Pt 1):1407-10. PubMed ID: 6593559
[TBL] [Abstract][Full Text] [Related]
13. Effect of PGE2 and indomethacin on human fibroblast collagen production.
Casini A; Nieri S; Banchetti E; Ricci OE; Calabrò A; Surrenti C
Boll Soc Ital Biol Sper; 1984 Jun; 60(6):1141-4. PubMed ID: 6591926
[TBL] [Abstract][Full Text] [Related]
14. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
Robertson FM; Simeone AM; Mazumdar A; Shah AH; McMurray JS; Ghosh S; Cristofanilli M
J Exp Ther Oncol; 2008; 7(4):299-312. PubMed ID: 19227010
[TBL] [Abstract][Full Text] [Related]
15. Hormone dependence of 7,12-dimethylbenz[a]anthracene-induced mammary tumor growth: correlation with prostaglandin E2 content.
Foecking MK; Kibbey WE; Abou-Issa H; Matthews RH; Minton JP
J Natl Cancer Inst; 1982 Aug; 69(2):443-6. PubMed ID: 6810004
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of prostaglandin E2 production by mononuclear cells and tumor cells in squamous cell carcinomas of the head and neck.
Milanovich MR; Snyderman CH; Wagner R; Johnson JT
Laryngoscope; 1995 Jan; 105(1):61-5. PubMed ID: 7837915
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms involved in prostaglandin E2-mediated neuroprotection against TNF-alpha: possible involvement of multiple signal transduction and beta-catenin/T-cell factor.
Lee EO; Shin YJ; Chong YH
J Neuroimmunol; 2004 Oct; 155(1-2):21-31. PubMed ID: 15342193
[TBL] [Abstract][Full Text] [Related]
18. The role of prostaglandins E2 and F2 alpha in ultraviolet radiation-induced cortical cataracts in vivo.
Andley UP; Fritz C; Morrison AR; Becker B
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1539-48. PubMed ID: 8675396
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2.
Kino Y; Kojima F; Kiguchi K; Igarashi R; Ishizuka B; Kawai S
Prostaglandins Leukot Essent Fatty Acids; 2005 Aug; 73(2):103-11. PubMed ID: 15963707
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
